An Update on Nanocarriers for Follicular-Targeted Drug Delivery for Androgenetic Alopecia Topical Treatment

    January 2025 in “ Expert Opinion on Drug Delivery
    Jayanaraian F. M. Andrade, Andrew Verbinnen, A. W. Bakst, Marcílio Cunha‐Filho, Guilherme M. Gelfuso, Taís Gratieri
    Image of study
    TLDR Nanocarriers could improve hair loss treatment but need more research for effectiveness and safety.
    The document reviews advancements in using nanocarriers for follicular-targeted drug delivery in treating androgenic alopecia. Current treatments like topical minoxidil and oral finasteride have limitations, such as side effects and formulation challenges. Nanocarriers offer a promising solution by naturally accumulating in hair follicles, potentially improving drug delivery. However, many studies lack proper controls and fail to quantify drug accumulation in skin layers, complicating comparisons between different nanocarriers. Future research should focus on a broader range of nanocarrier sizes, suitable skin models, and clinical tests to enhance treatment efficacy and safety.
    Discuss this study in the Community →

    Research cited in this study

    90 / 90 results

    Related Research

    10 / 10 results